Biotech Stocks Are Having Their Fine Day In View That February

The SPDR S&P Biotech ETF is on pace to have its best single day of trading since late February.
Clovis is trading at its highest levels since November 2015 and is on pace for its best day since June 2013, when it rose nearly 104 percent in a single day.
The Boulder, Colorado-based biopharma said data on its ovarian cancer drug shows treatment could benefit four times as many patients as expected.
Only nine of the 92 stocks within the ETF are not trading upward, with many rising 3 percent or more.
The fund, which tracks stocks in the S&P Biotechnology Select Industry Index, is up 4 percent on Monday, boosted by Clovis Oncology shares surging 46 percent after the company reported positive cancer drug data.

Read more on: